Literature DB >> 29784471

Rotavirus gastroenteritis surveillance in Azerbaijan, 2011-2016.

Nazifa Mursalova1, Nazim Shugayev2, Javahir Suleymanova3, Danni S Daniels4, Annemarie Wasley4, Adam L Cohen5, Negar Aliabadi6.   

Abstract

INTRODUCTION: Rotavirus is a leading cause of acute gastroenteritis and mortality among children worldwide but data describing rotavirus disease in Azerbaijan are lacking. This analysis describes the rotavirus disease burden in Baku, the largest city in Azerbaijan.
METHODS: We conducted active, prospective, sentinel hospital surveillance with laboratory confirmation for rotavirus among children under 5 years of age hospitalized at a large pediatric hospital in Baku during 2011-2016. Children with bloody diarrhea, or prior use of antibiotics or intravenous fluids were excluded. The guardians of enrolled children completed a questionnaire documenting clinical and demographic information. A stool specimen was collected from each enrolled child. We report the number and proportion of rotavirus positive hospitalizations during the surveillance period and a clinical description of rotavirus-positive and rotavirus-negative children.
RESULTS: From July 2011 through June 2016, 3139 children <5 years of age were enrolled into the surveillance system. Of these, 523 (17%) were positive for rotavirus, varying from 13% to 21% by surveillance year, with a median of 16% over the surveillance period. Increase in rotavirus detections occurred during December-May. Most rotavirus infections (303/523; 58%) occurred in children aged 6-23 months.
CONCLUSION: Rotavirus is responsible for approximately 16% of annual hospital admissions for acute gastroenteritis in children <5 years of age in Baku. This is lower than regional estimates. Exclusion of children with a history of antibiotic use or intravenous fluids may be accounting for this lower prevalence, and expansion of surveillance to include these groups could provide a more comprehensive picture of acute rotavirus gastroenteritis in Baku. Published by Elsevier Ltd.

Entities:  

Keywords:  Acute gastroenteritis; Diarrhea surveillance; Pediatric; Rotavirus

Mesh:

Year:  2018        PMID: 29784471      PMCID: PMC9169510          DOI: 10.1016/j.vaccine.2018.02.045

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   4.169


  11 in total

1.  Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Authors:  Deborah E Atherly; Kristen D C Lewis; Jacqueline Tate; Umesh D Parashar; Richard D Rheingans
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

2.  Rotavirus vaccines in Belgium: policy and impact.

Authors:  Tessa Braeckman; Koen Van Herck; Marc Raes; Anne Vergison; Martine Sabbe; Pierre Van Damme
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

Review 3.  Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014.

Authors:  Emilie Karafillakis; Sondus Hassounah; Christina Atchison
Journal:  Vaccine       Date:  2015-03-18       Impact factor: 3.641

Review 4.  Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality From Diarrhea.

Authors:  Eleanor Burnett; Christine L Jonesteller; Jacqueline E Tate; Catherine Yen; Umesh D Parashar
Journal:  J Infect Dis       Date:  2017-06-01       Impact factor: 5.226

5.  [Economic effectiveness of vaccination against rotavirus infection in the Russian Federation].

Authors:  M P Kostinov; V V Zverev
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  2012 May-Jun

6.  Cost-Effectiveness of Rotavirus Vaccination in France-Accounting for Indirect Protection.

Authors:  Dan Yamin; Katherine E Atkins; Vanessa Remy; Alison P Galvani
Journal:  Value Health       Date:  2016-07-15       Impact factor: 5.725

7.  Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children.

Authors:  Gayane Sahakyan; Svetlana Grigoryan; Annemarie Wasley; Liudmila Mosina; Shushan Sargsyan; Ara Asoyan; Zaruhi Gevorgyan; Karine Kocharyan; Tigran Avagyan; Benjamin Lopman; Artavazd Vanyan; Sergey Khactatryan; Umesh D Parashar; Margaret M Cortese
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

8.  Impact of Rotavirus Vaccine Introduction and Vaccine Effectiveness in the Republic of Moldova.

Authors:  Stela Gheorghita; Ludmila Birca; Ala Donos; Annemarie Wasley; Ion Birca; Radu Cojocaru; Anatol Melnick; Silviu Ciobanu; Liudmila Mosina; Margaret M Cortese; Umesh D Parashar; Ben Lopman
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

9.  Cost-effectiveness of rotavirus vaccination in Albania.

Authors:  Albana Ahmeti; Iria Preza; Artan Simaku; Erida Nelaj; Andrew David Clark; Ana Gabriela Felix Garcia; Carlos Lara; Céline Hoestlandt; Julia Blau; Silvia Bino
Journal:  Vaccine       Date:  2015-05-07       Impact factor: 3.641

10.  Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.

Authors:  Daniel Hungerford; Katie Smith; Angela Tucker; Miren Iturriza-Gómara; Roberto Vivancos; Catherine McLeonard; Nigel A Cunliffe; Neil French
Journal:  BMC Infect Dis       Date:  2017-08-15       Impact factor: 3.090

View more
  3 in total

1.  MiR-32-5p aggravates intestinal epithelial cell injury in pediatric enteritis induced by Helicobacter pylori.

Authors:  Jing Feng; Jian Guo; Jun-Ping Wang; Bao-Feng Chai
Journal:  World J Gastroenterol       Date:  2019-11-07       Impact factor: 5.742

2.  Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction.

Authors:  Adam L Cohen; Negar Aliabadi; Fatima Serhan; Jacqueline E Tate; Patrick Zuber; Umesh D Parashar
Journal:  Vaccine       Date:  2018-08-18       Impact factor: 4.169

3.  Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia.

Authors:  Karina A Top; Kristine Macartney; Julie A Bettinger; Ben Tan; Christopher C Blyth; Helen S Marshall; Wendy Vaudry; Scott A Halperin; Peter McIntyre
Journal:  Euro Surveill       Date:  2020-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.